SFM PARTICIPATION LP 4
Accession 0000950142-04-000030
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:36 PM ET
Size
29.6 KB
Accession
0000950142-04-000030
Insider Transaction Report
- Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total - Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying)
- Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying) - Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total
- Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying) - Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total
- Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying) - Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total
- Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying) - Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total
- Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total - Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying)
- Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total - Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying)
- Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total - Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying)
- Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total - Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying)
- Purchase
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 totalExercise: $3.00From: 2003-12-31Exp: 2008-12-31→ Common Stock (195,122 underlying) - Purchase
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805$1,000,000→ 1,892,334 total
Footnotes (4)
- [F1]Perseus-Soros BioPharmaceutical Fund, L.P. ("Perseus-Soros") acquired a Common Stock Purchase Warrant (the "Warrant") to acquire 195,122 shares of Common Stock. The aggregate purchase price of the Common Stock purchased as reported in Table I and the Warrant was $1 million. The Common Stock underlying the Warrant may be purchased at a price per share equal to $3.00 (the "Exercise Price"). The Exercise Price and the number of shares issuable upon exercise of the Warrant will be subject to adjustment upon the occurrence of certain events as set forth in the Warrant.
- [F2]Further, exercise of the Warrant may be restricted based on the number of securities the holder thereof would be deemed to beneficially own upon exercise thereof. The Warrant is exercisable at any time, from the date of issuance until the five year anniversary thereof (the "Expiration Date"). At the Expiration Date, the Warrant may be automatically exercised on a "cashless exercise" basis if the market price on such date is greater than 102% of the Exercise Price. In the event that the volume-weighted market price of the Common Stock exceeds $5.00 for thirty consecutive trading days, the Company may require exercise of the Warrant.
- [F3]All of the securities reported herein are held for the account of Perseus-Soros. Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseus EC, LLC, a Delaware limited liability company ("Perseus EC"), is the managing member of Perseus Partners. Perseuspur, LLC, a Delaware limited liability company ("Perseuspur"), is a member of Perseus EC. Mr. Frank H. Pearl ("Mr. Pearl") is the sole member of Perseuspur.
- [F4]SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. The sole managing member of SFM AH is Soros Fund Management LLC, a Delaware limited liability company ("SFM LLC"). Mr. George Soros serves as Chairman of SFM LLC.
Issuer
VALENTIS INC
CIK 0000932352
Related Parties
1- filerCIK 0001253598
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 3:36 PM ET
- Size
- 29.6 KB